Subscribe
Investor pressure has forced the company to change course
A step change in fiscal policy has boosted a range of contractors
Medium-term targets are in sight
The bargain valuation could attract takeover interest
Benefits from Europe turnaround plan expected in the second half
The S&P 500 is back in positive territory
End markets have been volatile, but the opportunity is clear
Earnings growth forecasts must be balanced against valuation
Tobacco pricing continues to offset lower volumes
The signs are that significant top-line growth will continue for this pharma and biotech technology company
